Cargando…
Hyperoxia combined with the B‐cell antagonist rituximab led to intestinal dysbiosis in neonatal mice
The adverse factors impacting the intestinal microbiota of newborns remain to be elucidated. We put forward a hypothesis that hyperoxia in combination with rituximab exhibits a synergistic effect that interferes with neonatal intestinal microbiota. Six C57BL/6J mice, aged 12 weeks and pregnant 18 da...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543333/ https://www.ncbi.nlm.nih.gov/pubmed/35524491 http://dx.doi.org/10.1111/1348-0421.12984 |